Impact of inflammatory preconditioning on murine microglial proteome response induced by focal ischemic brain injury

Preconditioning with LPS induces neuroprotection against subsequent cerebral ischemic injury, mainly involving innate immune pathways. Microglia are CNS-resident immune cells that respond early to danger signals through memory-like differential reprogramming. However, the cell-specific molecular mechanisms underlying preconditioning are not fully understood. To elucidate the distinct molecular mechanisms of preconditioning on microglia, we compared these cell-specific proteomic profiles in response to LPS preconditioning and without preconditioning and subsequent transient focal brain ischemia and reperfusion, – using an established mouse model of transient focal brain ischemia and reperfusion. A proteomic workflow, based on isolated microglia obtained from mouse brains by cell sorting and coupled to mass spectrometry for identification and quantification, was applied. Our data confirm that LPS preconditioning induces marked neuroprotection, as indicated by a significant reduction in brain infarct volume. The established brain cell separation method was suitable for obtaining an enriched microglial cell fraction for valid proteomic analysis. The results show a significant impact of LPS preconditioning on microglial proteome patterns by type I interferons, presumably driven by the interferon cluster regulator proteins Stat1/2.

[1]  D. Hübschmann,et al.  Simplify enrichment: A bioconductor package for clustering and visualizing functional enrichment results. , 2022, Genomics, proteomics & bioinformatics.

[2]  K. Hochrainer,et al.  Stroke Proteomics: From Discovery to Diagnostic and Therapeutic Applications. , 2022, Circulation research.

[3]  A. Brazma,et al.  The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences , 2021, Nucleic Acids Res..

[4]  C. B. Ransom,et al.  Microglial depletion abolishes ischemic preconditioning in white matter , 2021, Glia.

[5]  Zhao-Qi Wang,et al.  The Role of the Pathogen Dose and PI3Kγ in Immunometabolic Reprogramming of Microglia for Innate Immune Memory , 2021, International journal of molecular sciences.

[6]  Francesca N. Delling,et al.  Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association. , 2021, Circulation.

[7]  Á. Chamorro,et al.  The future of neuroprotection in stroke , 2020, Journal of Neurology, Neurosurgery, and Psychiatry.

[8]  C. Redecker,et al.  Cxcr4 distinguishes HSC-derived monocytes from microglia and reveals monocyte immune responses to experimental stroke , 2020, Nature Neuroscience.

[9]  T. Möller,et al.  Ischemic preconditioning induces cortical microglial proliferation and a transcriptomic program of robust cell cycle activation , 2020, Glia.

[10]  Trim Lajqi,et al.  Memory-Like Inflammatory Responses of Microglia to Rising Doses of LPS: Key Role of PI3Kγ , 2019, Front. Immunol..

[11]  Gennady Korotkevich,et al.  Fast gene set enrichment analysis , 2019, bioRxiv.

[12]  G. Rosenberg,et al.  Neuroinflammation: friend and foe for ischemic stroke , 2019, Journal of Neuroinflammation.

[13]  F. de Leeuw,et al.  Stroke incidence in young adults according to age, subtype, sex, and time trends , 2019, Neurology.

[14]  Fares Alahdab,et al.  Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2019, The Lancet Neurology.

[15]  P. Proost,et al.  How post-translational modifications influence the biological activity of chemokines. , 2018, Cytokine.

[16]  E. Lindsay Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct , 2018 .

[17]  I. Amit,et al.  Mef2C restrains microglial inflammatory response and is lost in brain ageing in an IFN-I-dependent manner , 2017, Nature Communications.

[18]  T. Möller,et al.  Ischemia/Reperfusion Induces Interferon-Stimulated Gene Expression in Microglia , 2017, The Journal of Neuroscience.

[19]  D. DeGracia,et al.  Regulation of mRNA following brain ischemia and reperfusion , 2017, Wiley interdisciplinary reviews. RNA.

[20]  Roland Eils,et al.  Complex heatmaps reveal patterns and correlations in multidimensional genomic data , 2016, Bioinform..

[21]  J. Weinstein,et al.  Neuroimmune Response in Ischemic Preconditioning , 2016, Neurotherapeutics.

[22]  Chun Jimmie Ye,et al.  Parsing the Interferon Transcriptional Network and Its Disease Associations , 2016, Cell.

[23]  Fen-Lei F Chang,et al.  Interferon‐β Modulates Inflammatory Response in Cerebral Ischemia , 2016, Journal of the American Heart Association.

[24]  L. Lind,et al.  Discovery of New Risk Markers for Ischemic Stroke Using a Novel Targeted Proteomics Chip , 2015, Stroke.

[25]  B. Ransom,et al.  Ischemic Preconditioning in White Matter: Magnitude and Mechanism , 2015, The Journal of Neuroscience.

[26]  Matthias Mann,et al.  Cell type– and brain region–resolved mouse brain proteome , 2015, Nature Neuroscience.

[27]  C. Iadecola,et al.  Immune mechanisms in cerebral ischemic tolerance , 2014, Front. Neurosci..

[28]  L. Ivashkiv,et al.  Regulation of type I interferon responses , 2013, Nature Reviews Immunology.

[29]  Toshiro K. Ohsumi,et al.  The Microglial Sensome Revealed by Direct RNA Sequencing , 2013, Nature Neuroscience.

[30]  Weijun Luo,et al.  Pathview: an R/Bioconductor package for pathway-based data integration and visualization , 2013, Bioinform..

[31]  Tao Yang,et al.  Poly‐ICLC preconditioning protects the blood–brain barrier against ischemic injury in vitro through type I interferon signaling , 2012, Journal of neurochemistry.

[32]  P. Corso,et al.  Silent brain injury after cardiac surgery: a review: cognitive dysfunction and magnetic resonance imaging diffusion-weighted imaging findings. , 2012, Journal of the American College of Cardiology.

[33]  Labchan Rajbhandari,et al.  Toll/Interleukin-1 Receptor Domain-Containing Adapter Inducing Interferon-β Mediates Microglial Phagocytosis of Degenerating Axons , 2012, The Journal of Neuroscience.

[34]  R. Simon,et al.  Toll-Like Receptor 7 Preconditioning Induces Robust Neuroprotection Against Stroke by a Novel Type I Interferon-Mediated Mechanism , 2012, Stroke.

[35]  L. Kenny,et al.  ‘Omic’ technologies: genomics, transcriptomics, proteomics and metabolomics , 2011 .

[36]  Tao Yang,et al.  Multiple Preconditioning Paradigms Converge on Interferon Regulatory Factor-Dependent Signaling to Promote Tolerance to Ischemic Brain Injury , 2011, The Journal of Neuroscience.

[37]  M. Mann,et al.  Andromeda: a peptide search engine integrated into the MaxQuant environment. , 2011, Journal of proteome research.

[38]  G. Moneta New ischemic brain lesions on MRI after stenting or endarterectomy for symptomatic carotid stenosis: a substudy of the International Carotid Stenting Study (ICSS) , 2011 .

[39]  Hanbo Chen,et al.  VennDiagram: a package for the generation of highly-customizable Venn and Euler diagrams in R , 2011, BMC Bioinformatics.

[40]  H. Jäger,et al.  New ischaemic brain lesions on MRI after stenting or endarterectomy for symptomatic carotid stenosis: a substudy of the International Carotid Stenting Study (ICSS) , 2010, Lancet Neurology.

[41]  C. Harrington,et al.  Systemic Lipopolysaccharide Protects the Brain from Ischemic Injury by Reprogramming the Response of the Brain to Stroke: A Critical Role for IRF3 , 2009, The Journal of Neuroscience.

[42]  U. Dirnagl,et al.  Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use , 2009, The Lancet Neurology.

[43]  H. Neumann,et al.  Debris clearance by microglia: an essential link between degeneration and regeneration , 2008, Brain : a journal of neurology.

[44]  M. Mann,et al.  MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification , 2008, Nature Biotechnology.

[45]  R. Simon,et al.  Toll-Like Receptor 9: A New Target of Ischemic Preconditioning in the Brain , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[46]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[47]  M. Mattson,et al.  Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits , 2007, Proceedings of the National Academy of Sciences.

[48]  C. Iadecola,et al.  Neurovascular Protection by Ischemic Tolerance: Role of Nitric Oxide and Reactive Oxygen Species , 2007, The Journal of Neuroscience.

[49]  C. Geula,et al.  Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease , 2007, Nature Medicine.

[50]  Steven P Gygi,et al.  Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry , 2007, Nature Methods.

[51]  J. S. King,et al.  Preconditioning Reprograms the Response to Ischemic Injury and Primes the Emergence of Unique Endogenous Neuroprotective Phenotypes: A Speculative Synthesis , 2007, Stroke.

[52]  M. Minami,et al.  Endotoxin preconditioning protects against the cytotoxic effects of TNFalpha after stroke: a novel role for TNFalpha in LPS-ischemic tolerance. , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[53]  J. Gidday Cerebral preconditioning and ischaemic tolerance , 2006, Nature Reviews Neuroscience.

[54]  C. Maier,et al.  Interferon-beta fails to protect in a model of transient focal stroke. , 2006, Stroke.

[55]  E. Ringelstein,et al.  Predominant phagocytic activity of resident microglia over hematogenous macrophages following transient focal cerebral ischemia: An investigation using green fluorescent protein transgenic bone marrow chimeric mice , 2005, Experimental Neurology.

[56]  W. Gan,et al.  ATP mediates rapid microglial response to local brain injury in vivo , 2005, Nature Neuroscience.

[57]  M. Minami,et al.  Endotoxin Preconditioning Prevents Cellular Inflammatory Response During Ischemic Neuroprotection in Mice , 2004, Stroke.

[58]  D. Weissman,et al.  Inhibition of Toll-like Receptor and Cytokine Signaling—A Unifying Theme in Ischemic Tolerance , 2004, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[59]  K. Nicolay,et al.  Interferon-Beta Blocks Infiltration of Inflammatory Cells and Reduces Infarct Volume after Ischemic Stroke in the Rat , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[60]  Ulrich Dirnagl,et al.  Ischemic tolerance and endogenous neuroprotection , 2003, Trends in Neurosciences.

[61]  Gene Ontology Consortium The Gene Ontology (GO) database and informatics resource , 2003 .

[62]  John Quackenbush Microarray data normalization and transformation , 2002, Nature Genetics.

[63]  T. Kirino Ischemic Tolerance , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[64]  Bernard Dupuis,et al.  Increase in Endogenous Brain Superoxide Dismutase as a Potential Mechanism of Lipopolysaccharide-Induced Brain Ischemic Tolerance , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[65]  Paul J. Kurtin,et al.  Immunohistochemical demonstration of the lysosome-associated glycoprotein CD68 (KP-1) in granular cell tumors and schwannomas. , 1994, Human pathology.

[66]  M. Moskowitz,et al.  Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. , 1994, Science.

[67]  L. Pitts,et al.  Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. , 1986, Stroke.